Literature DB >> 16019438

Negative regulation of PTK signalling by Cbl proteins.

Christine B F Thien1, Wallace Y Langdon.   

Abstract

Signalling pathways that are activated by ligands binding to cell surface receptors are responsible for determining many aspects of cellular function and fate. Although this outcome is primarily determined by the nature of the ligand and its receptor, it is also essential that the array of intracellular enzymes, adaptor proteins and transcription factors are correctly assembled to convey the intended response. In recent years it has become apparent that proteins which regulate the amplitude and duration of these responses can also affect cell function and fate. The Cbl family of E3 ubiquitin ligases and adaptor proteins have now emerged as key negative regulators of signals from many surface receptors. Although the array of these receptors is diverse, they have a common link in that they either possess a tyrosine kinase domain or they form associations with cytoplasmic protein tyrosine kinases (PTKs). Thus Cbl proteins become involved in signaling responses at a time when PTKs are first activated and therefore provide an initial line of defense to ensure signaling responses proceed at the desired intensity and kinetics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019438     DOI: 10.1080/08977190500153763

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  33 in total

1.  CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2.

Authors:  Paula Aranaz; Cristina Hurtado; Ignacio Erquiaga; Itziar Miguéliz; Cristina Ormazábal; Ion Cristobal; Marina García-Delgado; Francisco Javier Novo; José Luis Vizmanos
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  c-Cbl-mediated regulation of LAT-nucleated signaling complexes.

Authors:  Lakshmi Balagopalan; Valarie A Barr; Connie L Sommers; Mira Barda-Saad; Amrita Goyal; Matthew S Isakowitz; Lawrence E Samelson
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

3.  The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.

Authors:  Jianmin Sun; Malin Pedersen; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

4.  Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.

Authors:  Margret S Fernandes; Mamatha M Reddy; Nicole J Croteau; Christoph Walz; Henry Weisbach; Klaus Podar; Hamid Band; Martin Carroll; Andreas Reiter; Richard A Larson; Ravi Salgia; James D Griffin; Martin Sattler
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

Review 5.  Endocytosis of receptor tyrosine kinases.

Authors:  Lai Kuan Goh; Alexander Sorkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

Review 6.  Lipid rafts and B cell signaling.

Authors:  Neetu Gupta; Anthony L DeFranco
Journal:  Semin Cell Dev Biol       Date:  2007-07-24       Impact factor: 7.727

Review 7.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

Review 8.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

9.  Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Biomark Insights       Date:  2007-02-14

10.  Cbl negatively regulates JNK activation and cell death.

Authors:  Andrew A Sproul; Zhiheng Xu; Michael Wilhelm; Stephen Gire; Lloyd A Greene
Journal:  Cell Res       Date:  2009-08       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.